FDA expanded licensure of PCV13 to include adults ages 50 years and older
On Jun. 7, 2012, the FDA expanded licensure of PCV13 for prevention of pneumococcal disease to include adults ages 50 years and older.
Tags:
Source: U.S. Centers for Disease Control and Prevention
Credit:
